
Pyxis Oncology Inc Investor Relations Material
Latest events

Status Update
Pyxis Oncology Inc

Q1 2025
14 May, 2025

Q4 2024
18 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pyxis Oncology Inc
Access all reports
Pyxis Oncology Inc. is a clinical-stage biopharmaceutical company focused on developing therapies to treat cancer. It is focused on helping patients with cancer through a differentiated portfolio of biologics, specifically targeting tumor cells and overcoming immune suppression. Pyxis Oncology's strategy encompasses the use of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies, aiming to improve outcomes for patients with difficult-to-treat cancers. The company is headquartered in Boston, MA, and its shares are listed on the Nasdaq.
Key slides for Pyxis Oncology Inc


Q2 2024
Pyxis Oncology Inc


Q2 2024
Pyxis Oncology Inc
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
PYXS
Country
🇺🇸 United States